Treatment of acute and chronic viral hepatitis

Abb, 1985, Production of interferon alpha and interferon gamma by peripheral blood leucocytes from patients with chronic hepatitis B virus infection, Journal of Medical Virology, 16, 171, 10.1002/jmv.1890160209 Alberti, 1984, Antibody precipitating Dane particles in acute hepatitis type B: relation to receptors that bind polymerised human serum albumin on virus particles, Hepatology, 4, 220, 10.1002/hep.1840040209 Aldershvile, 1982, Chronic persistent hepatitis: serological classification and meaning of the hepatitis Be system, Hepatology, 2, 243, 10.1002/hep.1840020209 Alexander, 1986, Antiviral treatment in chronic infection with hepatitis B virus, British Medical Journal, 292, 915, 10.1136/bmj.292.6525.915 Alexander, 1986, Differential effect of ARA-AMP on serum DNA-polymerase activity and serum HBV-DNA in chronic hepatitis B virus infection, Journal of Hepatology, 3, 81, 10.1016/S0168-8278(86)80104-0 Alexander, 1987, Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection, Lancet, ii, 66, 10.1016/S0140-6736(87)92735-8 Alexander, 1987, A controlled trial of Acyclovir in chronic hepatitis B virus infection, Journal of Medical Virology, 21, 81, 10.1002/jmv.1890210111 Anderson, 1987, Randomised controlled trial of lymphoblastoid interferon in chronic active hepatitis B, Gut, 28, 619, 10.1136/gut.28.5.619 Bassendine, 1981, Adenine arabinoside therapy in HBsAg positive chronic liver disease-a controlled study, Gastroenterology, 80, 1016, 10.1016/0016-5085(81)90075-5 Bortolotti, 1986, Liver cirrhosis associated with chronic hepatitis B virus infection in childhood, Journal of Pediatrics, 198, 224, 10.1016/S0022-3476(86)80987-8 Brechot, 1985, Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen, New England Journal of Medicine, 312, 270, 10.1056/NEJM198501313120503 Budkowska, 1986, Hepatitis B virus pre-S gene encoded antigenic specificity and anti pre-S antibody: relationship between anti pre-S response and recovery, Hepatology, 6, 360, 10.1002/hep.1840060305 Chadwick, 1978, HBsAg positive chronic liver disease: inhibition of DNA polymerase activity by Vidarabine, British Medical Journal, 2, 531, 10.1136/bmj.2.6136.531 Chu, 1985, Natural history of chronic hepatitis virus infection in Taiwan: studies of hepatitis B virus DNA in serum, Hepatology, 5, 431, 10.1002/hep.1840050315 Colucci, 1983, In situ characterisation by mononuclear antibodies of the mononuclear cell infiltration in chronic active hepatitis, Gastroenterology, 85, 1138, 10.1016/S0016-5085(83)80082-1 Davis, 1986, Interferon in viral hepatitis: role in pathogenesis and treatment, Hepatology, 6, 1038, 10.1002/hep.1840060537 Davis, 1984, Spontaneous reactivation of chronic hepatitis B virus infection, Gastroenterology, 86, 230, 10.1016/0016-5085(84)90406-2 Degroote, 1978, Long term follow up of chronic active hepatitis of moderate severity, Gut, 19, 510, 10.1136/gut.19.6.510 Dudley, 1972, Natural history of hepatitis associated antigen positive chronic liver disease, Lancet, ii, 1388, 10.1016/S0140-6736(72)92963-7 Dusheiko, 1985, Recombinant leukocyte interferon treatment of chronic hepatitis B, Hepatology, 5, 556, 10.1002/hep.1840050406 Eggink, 1982, Cellular and humoral immune reactions in chronic active liver disease. 1. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis, Clinical and Experimental Immunology, 50, 17 Fagan, 1986, Persistence of free HBV DNA in body secretions and liver despite loss of serum HBV DNA after interferon induced seroconversion, Journal of Medical Virology, 20, 183, 10.1002/jmv.1890200210 Fattovich, 1982, Virological changes in chronic hepatitis type B treated with Levamisole, Digestion, 25, 131, 10.1159/000198821 Fattovich, 1986, Levamisole therapy in chronic type B hepatitis, 91, 692 Fiume, 1988, Inhibition of Hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin, Lancet, ii, 13, 10.1016/S0140-6736(88)92946-7 Galbraith, 1975, Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy, Lancet, ii, 528, 10.1016/S0140-6736(75)90897-1 Gerlich, 1987, Presurface and precore products of human hepatitis B virus, 147 Govindarajan, 1984, Fulminant hepatitis B, 86, 1417 Greenberg, 1976, Effect of human leucocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis, New England Journal of Medicine, 295, 517, 10.1056/NEJM197609022951001 Gregory, 1976, Steroid therapy in severe viral hepatitis: a double blind randomised trial of methyl prednisolone versus placebo, New England Journal of Medicine, 299, 690 Guarascio, 1986, Treatment of chronic HBe antigen positive hepatitis with acyclovir: a controlled trial, Journal of Hepatology, 3, S143, 10.1016/S0168-8278(86)80113-1 Hess, 1986, Treatment of hepatitis B surface antigen positive chronic hepatitis with recombinant leucocyte alpha A interferon, Journal of Hepatology, 3, S245, 10.1016/S0168-8278(86)80128-3 Hoofnagle, 1986, Treatment of chronic HDV hepatitis with alpha recombinant interferon in the USA Hoofnagle, 1981, Seroconversion from hepatitis Be antigen to antibody in chronic type B hepatitis, Annals of Internal Medicine, 91, 744, 10.7326/0003-4819-94-6-744 Hoofnagle, 1982, Reactivation of chronic hepatitis B virus infection by cancer chemotherapy, Annals of Internal Medicine, 96, 447, 10.7326/0003-4819-96-4-447 Hoofnagle, 1984, Randomised controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis, Gastroenterology, 86, 150, 10.1016/0016-5085(84)90601-2 Hoofnagle, 1986, Treatment of chronic non-A, non-B hepatitis with combinant human alpha interferon, New England Journal of Medicine, 315, 1575, 10.1056/NEJM198612183152503 Hsu, 1987, Biologic and prognostic significance of hepatocyte hepatitis B core antigen expressions in the natural course of chronic hepatitis B virus, Journal of Hepatology, 5, 45, 10.1016/S0168-8278(87)80060-0 Ikeda, 1986, Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life, Hepatology, 5, 962, 10.1002/hep.1840060525 Jilbert, 1986, Cellular localization of alpha interferon in hepatitis B virus-infected liver tissue, Hepatology, 6, 957, 10.1002/hep.1840060524 Kato, 1982, Interferon production by peripheral lymphocytes in HBsAg positive liver disease, Hepatology, 2, 789, 10.1002/hep.1840020607 Lai, 1987, Placebo controlled trial of recombinant alpha 2 interferon in Chinese HBsAg carrier children, Lancet, ii, 877, 10.1016/S0140-6736(87)91371-7 Lam, 1981, Deleterious effect of prednisolone in HBsAg positive chronic active hepatitis, New England Journal of Medicine, 304, 380, 10.1056/NEJM198102123040702 Leiberman, 1983, Detection of hepatitis B virus DNA directly in human serum by a simplified molecular hybridisation test, 3, 285 Liaw, 1983, Clinical and histological events preceding hepatitis Be antigen seroconversion in chronic type B hepatitis, Gastroenterology, 34, 216, 10.1016/S0016-5085(83)80114-0 Lo, 1982, The natural history of hepatitis B surface antigen positive chronic liver disease in Taiwan, Journal of Infectious Diseases, 146, 205, 10.1093/infdis/146.2.205 Lok, 1984, Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication, Liver, 4, 45, 10.1111/j.1600-0676.1984.tb00906.x Lok, 1988, Long-term follow up in a randomised control trial of recombinant alpha 2-interferon in Chinese patients with chronic hepatitis B infection, Lancet, ii, 298, 10.1016/S0140-6736(88)92355-0 McDonald, 1987, Interferons as mediators of psychiatric morbidity, Lancet, ii, 1175, 10.1016/S0140-6736(87)91319-5 Mondelli, 1982, Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes, Journal of Immunology, 129, 2773, 10.4049/jimmunol.129.6.2773 Naumov, 1984, Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic HBV infection, Hepatology, 4, 63, 10.1002/hep.1840040111 Nouri-Aria, 1986, In vitro study of IgG production and Concanavalin A induced suppressor cell function in acute and chronic hepatitis B virus infection, Clinical and Experimental Immunology, 64, 50 Novick, 1985, Diminished responsiveness of homosexual men to antiviral therapy for HBsAg positive chronic liver disease, Journal of Hepatology, 1, 29, 10.1016/S0168-8278(85)80065-9 Okamoto, 1986, Antibody to the receptor for polymerised human serum albumin in acute and persistent infection with hepatitis B virus, Hepatology, 6, 354, 10.1002/hep.1840060304 Perrillo, 1985, Comparative efficacy of adenine arabinoside 5′ monophosphate and prednisone withdrawal followed by adenine arabinoside 5′ monophosphate in the treatment of chronic active hepatitis type B, Gastroenterology, 88, 780, 10.1016/0016-5085(85)90151-9 Pignatelli, 1987, Cytotoxic T cell responses to the nucleocapsid proteins of HBV in chronic hepatitis, Journal of Hepatology, 4, 15, 10.1016/S0168-8278(87)80004-1 Pollard, 1978, Effect of Vidarabine on chronic hepatitis B virus infection, Journal of the American Medical Association, 239, 1648, 10.1001/jama.1978.03280430064020 Pontisso, 1987, Recombinant HBsAg particles containing pre-S proteins bind to human liver plasma membranes, 205 Preiksaitis, 1981, The effect of liver disease on pharmacokinetics and toxicity of 9β-d-arabinofuranosyladenine 5′monophosphate, Journal of Infectious Diseases, 144, 358, 10.1093/infdis/144.4.358 Rakela, 1983, Effect of short term prednisolone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis, Gastroenterology, 84, 956, 10.1016/0016-5085(83)90197-X Realdi, 1980, Seroconversion from hepatitis B antigen to anti-HBe in chronic hepatitis B virus infection, Gastroenterology, 79, 195, 10.1016/0016-5085(80)90130-4 Roda, 1988, Use of lymphoblastoid interferon in chronic type B hepatitis: a randomised controlled trial, American Journal of Medicine Sacks, 1979, Toxicity of vidarabine, Journal of the Medical Association, 241, 28, 10.1001/jama.1979.03290270020010 Sagnelli, 1980, Serum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HBsAg positive chronic active hepatitis, Lancet, ii, 395, 10.1016/S0140-6736(80)90442-0 Sampliner, 1979, The liver histology and frequency of clearance of the hepatitis B surface antigen in chronic carriers, American Journal of Medical Science, 277, 17, 10.1097/00000441-197901000-00002 Saracco, 1987, Rapidly progressive HBsAg positive hepatitis in Italy, 5, 274 Schalm, 1988, Combination treatment with interferon and acyclovir, American Journal of Medicine Schalm, 1976, Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis B s antigen, Gut, 17, 781, 10.1136/gut.17.10.781 Schalm, 1985, Acyclovir enhances the antiviral effect of interferon in chronic hepatitis B, Lancet, ii, 358, 10.1016/S0140-6736(85)92498-5 Scullard, 1981, Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B, Gastroenterology, 81, 987, 10.1016/S0016-5085(81)80002-9 Scullard, 1981, Antiviral treatment of chronic hepatitis B virus infection. 1) Changes in viral markers with interferon combined with adenine arabinoside, Journal of Infectious Diseases, 143, 772, 10.1093/infdis/143.6.772 Sherker, 1986, Foscarnet decreases serum and liver duck hepatitis virus DNA in chronically infected ducks, Gastroenterology, 91, 818, 10.1016/0016-5085(86)90681-5 Shouval, 1986, Conjugates between monoclonal antibodies to HBsAg and cytosine arabinoside, Journal of Hepatology, 3, S87, 10.1016/S0168-8278(86)80105-2 Smedile, 1982, Influence of delta infection on severity of hepatitis B, Lancet, ii, 945, 10.1016/S0140-6736(82)90156-8 Smith, 1983, Management of patients with HBsAg positive chronic active liver disease, 73 Smith, 1982, Vidarabine monophosphate and human leukocyte interferon in chronic hepatitis B infection, Journal of the American Medical Association, 247, 2261, 10.1001/jama.1982.03320410043029 Steis, 1988, Resistance to recombinant interferon alpha 2 a in hairy cell leukaemia associated with neutralising anti-interferon antibodies, New England Journal of Medicine, 318, 1409, 10.1056/NEJM198806023182201 Thomas, 1986, The treatment of chronic HDV hepatitis with lymphoblastoid interferon Thomas, 1983, Approaches to the treatment of chronic hepatitis B viral infection, 379 Thomas, 1986, Lymphoblastoid and recombinant alpha A interferon therapy of chronic hepatitis B virus infection, 3, S193 Thomson, 1987, Alpha interferon therapy for non-A, non-B hepatitis transmitted by gamma globulin replacement therapy, Lancet, i, 539, 10.1016/S0140-6736(87)90178-4 Tolentino, 1975, Decreased interferon response by lymphocytes from children with chronic hepatitis, Journal of Infectious Diseases, 132, 459, 10.1093/infdis/132.4.459 Trepo, 1984, Therapeutic efficacy of ARA AMP in symptomatic HBe antigen positive CAH: a randomised placebo controlled study, Hepatology, 4, 1055 1986, Steroids in chronic B hepatitis, 6, 227 Tur-Kaspa, 1986, Hepatitis B virus DNA contains a glucocorticoid responsive element, 83, 1627 Twu, 1987, Interaction between hepatitis B virus and human beta-interferon, 47 Vallbracht, 1985, Hepatitis A virus infection and the interferon system, Journal of Infectious Diseases, 152, 211, 10.1093/infdis/152.1.211 Vento, 1985, T lymphocyte sensitization to HBsAg and T cell mediated unresponsiveness to HBsAg in hepatitis B virus related chronic liver disease, Hepatology, 5, 192, 10.1002/hep.1840050206 Vento, 1987, Prospective study of cellular immunity of hepatitis B virus antigens from the early incubation phase of acute hepatitis B, Lancet, ii, 119, 10.1016/S0140-6736(87)92329-4 Viola, 1981, Natural history of liver disease in chronic hepatitis B surface antigen carriers: survey of 100 patients from Great Britain, Lancet, ii, 1156, 10.1016/S0140-6736(81)90600-0 Ware, 1981, A prospective trial of steroid therapy in severe viral hepatitis, 80, 219 Weller, 1982, Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5 prime monophosphate (ARA AMP), Gut, 23, 717, 10.1136/gut.23.9.717 Weller, 1982, The effects of prednisolone/ azathioprine in chronic hepatitis B viral infection, Gut, 23, 650, 10.1136/gut.23.8.650 Weller, 1983, Acyclovir in hepatitis B antigen positive chronic liver disease: inhibition of viral replication and transient renal impairment with IV bolus administration, Journal of Antimicrobial Chemotherapy, 11, 223, 10.1093/jac/11.3.223 Weller, 1986, A pilot study of BW A515U (6 deoxyacyclovir) in chronic hepatitis B virus infection, Journal of Hepatology, 3, S119, 10.1016/S0168-8278(86)80109-X Wu, 1982, Prednisolone in HBsAg positive chronic active hepatitis: histologic evaluation in a controlled prospective study, Hepatology, 2, 777, 10.1002/hep.1840020605 Yokosuka, 1985, Combination of short term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B, 89, 246